Increased hippocampal CA1 cerebral blood volume in schizophrenia

被引:51
作者
Talati, Pratik [1 ,2 ]
Rane, Swati [3 ]
Kose, Samet [2 ]
Blackford, Jennifer Urbano [2 ]
Gore, John [3 ]
Donahue, Manus J. [2 ,3 ]
Heckers, Stephan [2 ]
机构
[1] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37235 USA
[3] Vanderbilt Univ, Inst Imaging Sci, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA
关键词
Hippocampus; Cerebral blood volume; Schizophrenia; CA1; CA2/3; CBV; TREATED PATIENTS; DOPAMINE; GLUTAMATE; MEMORY; DYSFUNCTION; MODULATION; REGION; MODEL; ABNORMALITIES; INTERNEURONS;
D O I
10.1016/j.nicl.2014.07.004
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Hippocampal hyperactivity has been proposed as a biomarker in schizophrenia. However, there is a debate whether the CA1 or the CA2/3 subfield is selectively affected. We studied 15 schizophrenia patients and 15 matched healthy control subjects with 3T steady state, gadolinium-enhanced, absolute cerebral blood volume (CBV) maps, perpendicular to the long axis of the hippocampus. The subfields of the hippocampal formation (subiculum, CA1, CA2/3, and hilus/dentate gyrus) were manually segmented to establish CBV values. Comparing anterior CA1 and CA2/3 CBV between patients and controls revealed a significant subfield-by-diagnosis interaction. This interaction was due to the combined effect of a trend of increased CA1 CBV (p =.06) and non-significantly decreased CA2/3 CBV (p = 0.14) in patients relative to healthy controls. These results support the emerging hypothesis of increased hippocampal activity as a biomarker of schizophrenia and highlight the importance of subfield-level investigations. (C) 2014 The Authors. Published by Elsevier Inc.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 66 条
[1]   Do we still believe in the dopamine hypothesis? New data bring new evidence [J].
Abi-Dargham, A .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 :S1-S5
[2]   Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders [J].
Akbarian, Schahram ;
Huang, Hsien-Sung .
BRAIN RESEARCH REVIEWS, 2006, 52 (02) :293-304
[3]  
Aleman A, 1999, AM J PSYCHIAT, V156, P1358
[4]   THE 3-DIMENSIONAL ORGANIZATION OF THE HIPPOCAMPAL-FORMATION - A REVIEW OF ANATOMICAL DATA [J].
AMARAL, DG ;
WITTER, MP .
NEUROSCIENCE, 1989, 31 (03) :571-591
[5]   How well do we understand the neural origins of the fMRI BOLD signal? [J].
Arthurs, OJ ;
Boniface, S .
TRENDS IN NEUROSCIENCES, 2002, 25 (01) :27-31
[6]   Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens [J].
Blaha, CD ;
Yang, CR ;
Floresco, SB ;
Barr, AM ;
Phillips, AG .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (05) :902-911
[7]   Deficits in emotional learning and memory in an animal model of schizophrenia [J].
Bolton, Monica M. ;
Heaney, Chelcie F. ;
Sabbagh, Jonathan J. ;
Murtishaw, Andrew S. ;
Magcalas, Christy M. ;
Kinney, Jefferson W. .
BEHAVIOURAL BRAIN RESEARCH, 2012, 233 (01) :35-44
[8]  
Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[9]   AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages [J].
Cox, RW .
COMPUTERS AND BIOMEDICAL RESEARCH, 1996, 29 (03) :162-173
[10]   INCREASED TEMPORAL-LOBE GLUCOSE USE IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].
DELISI, LE ;
BUCHSBAUM, MS ;
HOLCOMB, HH ;
LANGSTON, KC ;
KING, AC ;
KESSLER, R ;
PICKAR, D ;
CARPENTER, WT ;
MORIHISA, JM ;
MARGOLIN, R ;
WEINBERGER, DR .
BIOLOGICAL PSYCHIATRY, 1989, 25 (07) :835-851